277 related articles for article (PubMed ID: 21606490)
1. Human interleukin-1 receptor-associated kinase-2 is essential for Toll-like receptor-mediated transcriptional and post-transcriptional regulation of tumor necrosis factor alpha.
Flannery SM; Keating SE; Szymak J; Bowie AG
J Biol Chem; 2011 Jul; 286(27):23688-97. PubMed ID: 21606490
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-1 receptor-associated kinase 2 is critical for lipopolysaccharide-mediated post-transcriptional control.
Wan Y; Xiao H; Affolter J; Kim TW; Bulek K; Chaudhuri S; Carlson D; Hamilton T; Mazumder B; Stark GR; Thomas J; Li X
J Biol Chem; 2009 Apr; 284(16):10367-75. PubMed ID: 19224918
[TBL] [Abstract][Full Text] [Related]
3. Toll-like receptor 2 dominance over Toll-like receptor 4 in stressful conditions for its detrimental role in the heart.
Bagchi AK; Akolkar G; Mandal S; Ayyappan P; Yang X; Singal PK
Am J Physiol Heart Circ Physiol; 2017 Jun; 312(6):H1238-H1247. PubMed ID: 28432060
[TBL] [Abstract][Full Text] [Related]
4. IRAK-2 participates in multiple toll-like receptor signaling pathways to NFkappaB via activation of TRAF6 ubiquitination.
Keating SE; Maloney GM; Moran EM; Bowie AG
J Biol Chem; 2007 Nov; 282(46):33435-33443. PubMed ID: 17878161
[TBL] [Abstract][Full Text] [Related]
5. Pellino-1 Positively Regulates Toll-like Receptor (TLR) 2 and TLR4 Signaling and Is Suppressed upon Induction of Endotoxin Tolerance.
Murphy M; Xiong Y; Pattabiraman G; Qiu F; Medvedev AE
J Biol Chem; 2015 Jul; 290(31):19218-32. PubMed ID: 26082489
[TBL] [Abstract][Full Text] [Related]
6. TAK1 contributes to the enhanced responsiveness of LTB(4)-treated neutrophils to Toll-like receptor ligands.
Gaudreault É; Paquet-Bouchard C; Fiola S; Le Bel M; Lacerte P; Shio MT; Olivier M; Gosselin J
Int Immunol; 2012 Nov; 24(11):693-704. PubMed ID: 22843747
[TBL] [Abstract][Full Text] [Related]
7. Bacterial lipoprotein-induced tolerance is reversed by overexpression of IRAK-1.
Li CH; Liu J; An M; Redmond HP; Wang JH
Immunol Cell Biol; 2012 Mar; 90(3):314-20. PubMed ID: 21537341
[TBL] [Abstract][Full Text] [Related]
8. TLR2- and TLR4-mediated signals determine attenuation or augmentation of inflammation by acute alcohol in monocytes.
Oak S; Mandrekar P; Catalano D; Kodys K; Szabo G
J Immunol; 2006 Jun; 176(12):7628-35. PubMed ID: 16751410
[TBL] [Abstract][Full Text] [Related]
9. Human Toll-like Receptor 8 (TLR8) Is an Important Sensor of Pyogenic Bacteria, and Is Attenuated by Cell Surface TLR Signaling.
Moen SH; Ehrnström B; Kojen JF; Yurchenko M; Beckwith KS; Afset JE; Damås JK; Hu Z; Yin H; Espevik T; Stenvik J
Front Immunol; 2019; 10():1209. PubMed ID: 31214180
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-1 receptor-associated kinase-1 plays an essential role for Toll-like receptor (TLR)7- and TLR9-mediated interferon-{alpha} induction.
Uematsu S; Sato S; Yamamoto M; Hirotani T; Kato H; Takeshita F; Matsuda M; Coban C; Ishii KJ; Kawai T; Takeuchi O; Akira S
J Exp Med; 2005 Mar; 201(6):915-23. PubMed ID: 15767370
[TBL] [Abstract][Full Text] [Related]
11. Induction of TLR-2 and TLR-5 expression by Helicobacter pylori switches cagPAI-dependent signalling leading to the secretion of IL-8 and TNF-α.
Kumar Pachathundikandi S; Brandt S; Madassery J; Backert S
PLoS One; 2011 May; 6(5):e19614. PubMed ID: 21573018
[TBL] [Abstract][Full Text] [Related]
12. Involvement of interleukin-1 receptor-associated kinase (IRAK)-M in toll-like receptor (TLR) 7-mediated tolerance in RAW 264.7 macrophage-like cells.
Hassan F; Islam S; Tumurkhuu G; Dagvadorj J; Naiki Y; Komatsu T; Koide N; Yoshida T; Yokochi T
Cell Immunol; 2009; 256(1-2):99-103. PubMed ID: 19251253
[TBL] [Abstract][Full Text] [Related]
13. Induction of in vitro reprogramming by Toll-like receptor (TLR)2 and TLR4 agonists in murine macrophages: effects of TLR "homotolerance" versus "heterotolerance" on NF-kappa B signaling pathway components.
Dobrovolskaia MA; Medvedev AE; Thomas KE; Cuesta N; Toshchakov V; Ren T; Cody MJ; Michalek SM; Rice NR; Vogel SN
J Immunol; 2003 Jan; 170(1):508-19. PubMed ID: 12496438
[TBL] [Abstract][Full Text] [Related]
14. The CATERPILLER protein monarch-1 is an antagonist of toll-like receptor-, tumor necrosis factor alpha-, and Mycobacterium tuberculosis-induced pro-inflammatory signals.
Williams KL; Lich JD; Duncan JA; Reed W; Rallabhandi P; Moore C; Kurtz S; Coffield VM; Accavitti-Loper MA; Su L; Vogel SN; Braunstein M; Ting JP
J Biol Chem; 2005 Dec; 280(48):39914-24. PubMed ID: 16203735
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-1 receptor-associated kinase 2- and protein kinase D1-dependent regulation of IRAK-monocyte expression by CpG DNA.
Kim YI; Park JE; Kwon KH; Hong CY; Yi AK
PLoS One; 2012; 7(8):e43970. PubMed ID: 22928050
[TBL] [Abstract][Full Text] [Related]
16. Thalidomide inhibits lipopolysaccharide-induced tumor necrosis factor-alpha production via down-regulation of MyD88 expression.
Noman AS; Koide N; Hassan F; I-E-Khuda I; Dagvadorj J; Tumurkhuu G; Islam S; Naiki Y; Yoshida T; Yokochi T
Innate Immun; 2009 Feb; 15(1):33-41. PubMed ID: 19201823
[TBL] [Abstract][Full Text] [Related]
17. Differential post-transcriptional regulation of IL-10 by TLR2 and TLR4-activated macrophages.
Teixeira-Coelho M; Guedes J; Ferreirinha P; Howes A; Pedrosa J; Rodrigues F; Lai WS; Blackshear PJ; O'Garra A; Castro AG; Saraiva M
Eur J Immunol; 2014 Mar; 44(3):856-66. PubMed ID: 24227629
[TBL] [Abstract][Full Text] [Related]
18. Moesin-induced signaling in response to lipopolysaccharide in macrophages.
Zawawi KH; Kantarci A; Schulze-Späte U; Fujita T; Batista EL; Amar S; Van Dyke TE
J Periodontal Res; 2010 Oct; 45(5):589-601. PubMed ID: 20546116
[TBL] [Abstract][Full Text] [Related]
19. Toll-like receptor 4 mediates intracellular signaling without TNF-alpha release in response to Cryptococcus neoformans polysaccharide capsule.
Shoham S; Huang C; Chen JM; Golenbock DT; Levitz SM
J Immunol; 2001 Apr; 166(7):4620-6. PubMed ID: 11254720
[TBL] [Abstract][Full Text] [Related]
20. Dependence on p38 MAPK signalling in the up-regulation of TLR2, TLR4 and TLR9 gene expression in Trichomonas vaginalis-treated HeLa cells.
Chang JH; Park JY; Kim SK
Immunology; 2006 Jun; 118(2):164-70. PubMed ID: 16771851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
